Home
Indices
FTSE 100
Risers/Fallers
US Share Prices
Sectors
News
RNS
Watchlist
Portfolio
Login / Register
Close
Company Search
Become a Member
Track your favourite stocks
Create & monitor portfolios
Daily portfolio value
Sign Up
Quickpicks
£
%
Company
Chg
Chg %
Add shares to your
quickpicks to
display them here!
Share Prices
Astrazeneca Share Price
Astrazeneca Share News
Astrazeneca (AZN) Share News
142
143
144
145
146
147
148
149
150
151
AstraZeneca Type 2 Diabetes Treatment Recommended For Approval
22nd Nov 2013 14:10
Read More
UK BROKER RATING CHANGES: Barclays Initiates Housebuilders
20th Nov 2013 10:14
Read More
Allergy Therapeutics Revenues Up 16%, Appoints New R&D Director
20th Nov 2013 10:05
Read More
AstraZeneca Gets US Approval For Investigational Constipation Drug
19th Nov 2013 09:50
Read More
UK BROKER RATING CHANGES: Four Brokers Cut Centrica Price Target
15th Nov 2013 10:23
Read More
UK BROKER RATING CHANGES: Panmure Cuts AstraZeneca To Sell
13th Nov 2013 10:32
Read More
BTG Interim Profit Boosted By Acquisitions; Says On Track For Full Year
12th Nov 2013 11:40
Read More
UK PRESS: AstraZeneca To Invest GBP120 Million In New UK Plant - FT
12th Nov 2013 08:26
Read More
BROKER RATING CHANGES: Four Brokers Cut RBS Price Target
4th Nov 2013 10:05
Read More
DIRECTOR DEALINGS: AstraZeneca CEO Awarded 24,000 Shares
1st Nov 2013 16:14
Read More
CORRECT: AstraZeneca Says Patent Ruling Reversed On US Appeal But 2nd Patent Held Invalid
31st Oct 2013 12:07
Read More
2ND UPDATE: AstraZeneca Profit Hit By Loss Of Exclusivity, Names New CFO
31st Oct 2013 11:52
Read More
CORRECT: UPDATE: AstraZeneca Profit Hit By Loss Of Exclusivity, Names New CFO
31st Oct 2013 11:47
Read More
BROKER RATING CHANGES: Four Banks Raise Next Price Target
31st Oct 2013 10:08
Read More
AstraZeneca Says Patent Ruling Reversed On US Appeal But 2nd Patent Held Invalid
31st Oct 2013 08:35
Read More
UPDATE: AstraZeneca Profit Hit By Loss Of Exclusivity, Names New CFO
31st Oct 2013 08:27
Read More
AstraZeneca Posts Lower Q3 Profit; Names Marc Dunoyer CFO
31st Oct 2013 07:29
Read More
AstraZeneca Beings Phase III Trial Programme For Potential Severe Asthma Treatment
30th Oct 2013 09:27
Read More
BROKER RATING CHANGES: Jefferies Raises Sage Group To Buy
28th Oct 2013 10:12
Read More
UPDATE: AstraZeneca Launches Third Phase Of Clinical Programme For Cancer Treatment
22nd Oct 2013 09:06
Read More
142
143
144
145
146
147
148
149
150
151
FTSE 100 Latest
Value
10,600.53
Change
-2.95
